NASDAQ:AFIB Acutus Medical (AFIB) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free AFIB Stock Alerts $0.20 0.00 (0.00%) (As of 03/27/2024 ET) Add Compare Share Share Today's Range$0.19▼$0.2250-Day Range$0.17▼$0.3152-Week Range$0.16▼$1.09Volume1.44 million shsAverage Volume2.38 million shsMarket Capitalization$5.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Acutus Medical alerts: Email Address Ad Huge AlertsTrending Stocks Sent To You In Real Time Sign up today and get instant access to our next stock alert! You do not want to miss out on this next pick! Our stock picks have been known to soar! Click To Get Our Next Alert About Acutus Medical Stock (NASDAQ:AFIB)Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The company was incorporated in 2011 and is headquartered in Carlsbad, California.Read More AFIB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AFIB Stock News HeadlinesMarch 28, 2024 | msn.com'Much safer for patients': Nebraska Medicine rolls out new heart procedure for AFibMarch 25, 2024 | msn.comDiet and Sugary Drinks Linked to Higher Atrial Fibrillation Risk, Study ShowsMarch 28, 2024 | Huge Alerts (Ad)Trending Stocks Sent To You In Real Time Sign up today and get instant access to our next stock alert! You do not want to miss out on this next pick! Our stock picks have been known to soar! March 22, 2024 | msn.comBlood tests could identify people with AFib at risk for 'breakthrough' strokeMarch 18, 2024 | msn.comOpportunistic atrial fibrillation screening key to preventing strokesMarch 17, 2024 | ca.finance.yahoo.comAcutus Medical, Inc. (AFIB)March 15, 2024 | msn.comNew FDA-approved treatment for atrial fibrillation being used on Chicago-area patientsMarch 14, 2024 | msn.comUCHealth starts offering non-thermal treatment for A-fib patientsMarch 28, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…March 14, 2024 | msn.comCHRISTUS Highland first Louisiana hospital to treat atrial fibrillation with new technologyMarch 11, 2024 | msn.comArtificially Sweetened Drinks May Increase AFib Risk by 20%, Study FindsMarch 8, 2024 | msn.comSugary Sodas and Artificially Sweetened Drinks Can Raise Risk of Atrial Fibrillation by 20 PercentMarch 6, 2024 | msn.comStudy shows link between sweetened drinks and higher atrial fibrillation riskFebruary 28, 2024 | msn.comDrinking ice-cold water triggered atrial fibrillation for Houston manFebruary 26, 2024 | msn.comEngineered heart cells may improve understanding of atrial fibrillationFebruary 22, 2024 | msn.comAsk A Doctor: What Is The Life Expectancy Of Patients With Atrial Fibrillation?February 22, 2024 | msn.comPatients diagnosed with new-onset, persistent AFib are more likely to have certain risk factorsFebruary 20, 2024 | msn.comWhat Is The Life Expectancy Of Patients With Atrial Fibrillation? A Review By DoctorsFebruary 12, 2024 | msn.comOn Call with Dr. Kumar: Understanding atrial fibrillation, or a-fib, and ways to prevent itFebruary 9, 2024 | msn.comAcutus Medical Faces Biotronik Contract Termination DisputeFebruary 2, 2024 | msn.comAsk A Doctor: What Happens Within The Heart During Atrial Fibrillation?February 1, 2024 | msn.comProfessional Faqs: What Happens Within The Heart During Atrial Fibrillation?January 24, 2024 | msn.comWhat Should You Not Do If You Have Atrial Fibrillation? A Review By DoctorsJanuary 10, 2024 | msn.comAsk A Doctor: How Can We Prevent Atrial Fibrillation?January 8, 2024 | msn.comUpdate on mechanisms and management of atrial fibrillationJanuary 4, 2024 | msn.comNew Staging System for AFib Allows for More Nuanced Treatment, Experts SayJanuary 3, 2024 | msn.comWhy Did You Develop Atrial Fibrillation? A Review By DoctorsSee More Headlines Receive AFIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/11/2021Today3/27/2024Next Earnings (Estimated)3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:AFIB CUSIPN/A CIK1522860 Webwww.acutusmedical.com Phone442-232-6080Fax442-232-6081Employees225Year Founded2011Profitability EPS (Most Recent Fiscal Year)($1.24) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-39,620,000.00 Net Margins-166.79% Pretax Margin-165.99% Return on Equity-62.18% Return on Assets-30.19% Debt Debt-to-Equity Ratio1.10 Current Ratio4.92 Quick Ratio3.85 Sales & Book Value Annual Sales$16.36 million Price / Sales0.35 Cash FlowN/A Price / Cash FlowN/A Book Value$2.64 per share Price / Book0.08Miscellaneous Outstanding Shares29,300,000Free Float28,278,000Market Cap$5.80 million OptionableOptionable Beta0.19 Social Links 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Takeo Mukai (Age 43)CEO & CFO Mr. Gary W. Doherty (Age 58)Senior Vice President of Finance Comp: $434.32kKey CompetitorsTitan MedicalNASDAQ:TMDIFVivos TherapeuticsNASDAQ:VVOSSharps TechnologyNASDAQ:STSSMinerva SurgicalNASDAQ:UTRSGlucoTrackNASDAQ:GCTKView All CompetitorsInstitutional OwnershipVanguard Group Inc.Sold 854,622 shares on 3/11/2024Ownership: 0.976%Vanguard Group Inc.Sold 854,622 shares on 2/15/2024Ownership: 0.976%Citadel Advisors LLCBought 300 shares on 2/15/2024Ownership: 0.000%View All Institutional Transactions AFIB Stock Analysis - Frequently Asked Questions How have AFIB shares performed in 2024? Acutus Medical's stock was trading at $0.2019 at the beginning of the year. Since then, AFIB shares have decreased by 1.9% and is now trading at $0.1980. View the best growth stocks for 2024 here. Are investors shorting Acutus Medical? Acutus Medical saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 984,700 shares, a decrease of 33.0% from the February 29th total of 1,470,000 shares. Based on an average trading volume of 2,210,000 shares, the days-to-cover ratio is presently 0.4 days. Approximately 5.3% of the company's shares are sold short. View Acutus Medical's Short Interest. When is Acutus Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, March 28th 2024. View our AFIB earnings forecast. How were Acutus Medical's earnings last quarter? Acutus Medical, Inc. (NASDAQ:AFIB) issued its earnings results on Thursday, November, 11th. The company reported ($0.94) EPS for the quarter, missing the consensus estimate of ($0.92) by $0.02. The business earned $4.60 million during the quarter, compared to analyst estimates of $6.02 million. Acutus Medical had a negative net margin of 166.79% and a negative trailing twelve-month return on equity of 62.18%. During the same quarter in the previous year, the business earned ($1.18) EPS. What other stocks do shareholders of Acutus Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Acutus Medical investors own include Oak Street Health (OSH), Alibaba Group (BABA), Checkmate Pharmaceuticals (CMPI), Salesforce (CRM), Walt Disney (DIS), DocuSign (DOCU), Marvell Technology (MRVL), NVIDIA (NVDA), Tesla (TSLA) and Twilio (TWLO). When did Acutus Medical IPO? Acutus Medical (AFIB) raised $126 million in an IPO on Thursday, August 6th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. Who are Acutus Medical's major shareholders? Acutus Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (0.98%), Vanguard Group Inc. (0.98%), Citadel Advisors LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include James F Hinrichs, Orbimed Advisors Llc and R Scott Huennekens. View institutional ownership trends. How do I buy shares of Acutus Medical? Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Does Acutus Medical have any subsidiaries? The following companies are subsidiares of Acutus Medical: Acutus Medical N.V..Read More This page (NASDAQ:AFIB) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.